Eledon Pharmaceuticals Inc. (ELDN)
Eledon Pharmaceuticals Presents Long-Term Phase 1b Data for Tegoprubart in Kidney Transplant Patients at the American Society of Transplant Surgeons Winter Symposium
Eledon Pharmaceuticals Presents Long-Term Phase 1b Data for Tegoprubart in Kidney Transplant Patients at the American Society of Transplant Surgeons Winter Symposium
DEFA14A (Additional Proxy Soliciting Materials (definitive)) SEC Filing
Statement from Fresenius Medical Care on Upcoming Winter Storm
Penumbra Launches Lightning Flash 3.0 — The Next Evolution in CAVT Technology
ResMed Inc. Daily Stock Update
New Zynex Leadership Responds to Indictment of Former Executives
Aptar - Aptar Declares Quarterly Dividend and Announces 2026 Annual Meeting Details
UTHR: Notification
ClearPoint Neuro Announces EU MDR Certification for ClearPoint Navigation Software Version 3.0.2, Expanding Access to the Latest Operating Room Navigation Platform in Europe
Corvex Secures Long-Term NVIDIA H200 GPU Deployment with AI-driven Provider of High-Performance Battery Technologies to Support Production AI Workloads